Sepp-Lorenzino Laura

EDGAR CIK 0001777421

Intellia Therapeutics, Inc. - NTLA

  1. Manufacturing
  2. Chemicals
  3. In Vitro & In Vivo Diagnostic Substances
Officer
EVP, Chief Scientific Officer
Direct Buys
0
$0
0 Shares
Direct Sells
1
($109,206)
-8,966 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
01/03/2025
01/07/2025
Sell
-8,966 @ $12.18
 ($109,206) 77,388 (-10.38%) Direct